X0306 4 2013-11-19 0001311230 SOLAZYME INC SZYM 0001333277 Quinlan Paul T SOLAZYME, INC. 225 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080 0 1 0 0 General Counsel Common Stock 2013-11-19 4 S 0 6000 8.4098 D 77000 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.355 to $8.455, inclusive. The reporting person undertakes to provide to Solazyme, Inc., any security holder of Solazyme, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/ Paul Quinlan 2013-11-19